Development and Validation of a Discriminating In Vitro Dissolution Method for Oral Formulations Containing Satranidazole

Table 2

Stability data in 0.1 N HCL.

Time	Absorbance	Mean	SD	% RSD
30 minutes	0.757	—	—	—
1 hr	0.758	0.7575	0.00071	0.093
2 hrs	0.752	0.75567	0.00321	0.425
4 hrs	0.759	0.7565	0.00311	0.411
8 hrs	0.745	0.7542	0.00581	0.770
16 hrs	0.734	0.75083	0.00975	1.298
24 hrs	0.745	0.75	0.00917	1.222